PRODUCTS

INTERNATIONAL  /  RIVASTIGMINE «  BACK TO "INTERNATIONAL"

EU Approved

Oral solution
Product Pharmaceutical form Strengths Therapeutic category
  • Rivastigmine
  • Oral solution
  • 2mg/ml
  • Dementia of the Alzheimer type symptomatic treatment. Treatment of dementia in patients with idiopathic Parkinson's disease

Other products in "International"